Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma

Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma - Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma(FOREST)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032002

Enrollment

1000

Registered

2018-04-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Follicular lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Newly-diagnosed follicular lymphoma (Grade 1, 2, 3A, and 3B). 2) Treatment or follow-up is being scheduled at a participating hospital. 3) Aged 20 or over. 4) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) Past history of any type of malignant lymphoma. 2) Follicular lymphoma with diffuse large B-cell lymphoma. 3) Transformed follicular lymphoma.

Design outcomes

Primary

Measure	Time frame
Overall survival from diagnosis date	—

Countries

Japan

Contacts

Public ContactWataru Munakata

National Cancer Center Hospital Department of Hematology

TRIML1620@tri-kobe.org03-3542-2511

Outcome results